Loncar Cancer Immunotherapy ETF (CNCR) Stock Charts CNCR Home News Ratings Charts Dividends Loncar Cancer Immunotherapy ETF (CNCR): $14.96 0.22 (+1.49%) POWR Rating Get Rating Component Grades Buy & Hold C Peer D Trade Get Rating Add CNCR to Watchlist Sign Up Category: Health & Biotech ETFs Category C Ranked #31 of 42 in category See All 'A' Rated Buy ETFs Loncar Cancer Immunotherapy ETF (CNCR) Performance Graph for POWR Ratings Loncar Cancer Immunotherapy ETF (CNCR) Interactive Chart CNCR Chart by TradingView Loncar Cancer Immunotherapy ETF (CNCR) Ratings History Chart Free access to the full ratings history for CNCR. Sign up now! Most Popular Stories View All • Investors: Are You Ready for November? • 3 Cybersecurity Stocks Defending Against Digital Threats • 3 Oil Stocks With High Upside as Global Demand Rebounds • 3 Tech Stocks Under $10 That Could Deliver Big Gains • 2 Concerns for Investors in October View All Top stories Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Subscribe Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
